The company said it will address the observations and respond to the FDA within the stipulated timeframe, reaffirming its ...
An announcement from Acurx Pharmaceuticals ( ($ACXP) ) is now available. On September 16, 2025, Acurx Pharmaceuticals held a special meeting where ...
NDTV Profit on MSN
Lupin's Pune Facility Gets Four Observations After US FDA Inspection
The US FDA conducted a product-specific pre-approval inspection at the company’s Pune biotech facility from Sept. 8 to Sept.
While many of us were still worrying about Snapchat and screen time, teens had already expanded their digital repertoire.
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing based on four Phase 3 studies that met all primary and co-primary endpoints.
Japan biotech xFOREST Therapeutics is teaming up with a drug discovery solutions provider in a research pact aiming to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback